Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm

Fig 2

Key interactors in the predicted mechanism of action of pirfenidone and melatonin combination therapy targeting the coronavirus-host interaction set.

Fig 2

doi: https://doi.org/10.1371/journal.pone.0240149.g002